A radiologist and a cardiologist have been cleared of negligence in the diagnosis and treatment of actor John Ritter, whose family brought a $67 million wrongful death suit against the two physicians.
A radiologist and a cardiologist have been cleared of negligence in the diagnosis and treatment of actor John Ritter, whose family brought a $67 million wrongful death suit against the two physicians.
Ritter, 54, died of an aortic dissection in 2003. Two years earlier, radiologist Dr. Matthew Lotysch had performed a whole-body CT scan on him. During the trial, based in Glendale, CA, Lotysch testified that he did not consider Ritter's aorta to be enlarged based on the results.
Lotysch did warn the actor, however, that he had blocked coronary arteries and was at risk for heart disease. He urged Ritter to consult a cardiologist or an internist, Lotysch said. Other witnesses testified that Ritter ignored the radiologist's advice
In September 2003, Ritter collapsed on the set of the ABC sitcom "8 Simple Rules ... for Dating My Teenage Daughter" and was rushed to Providence St. Joseph Medical Center in Burbank, CA. He was treated for a heart attack but ultimately died of a torn aorta.
According to trial testimony, a chest x-ray had been ordered as soon as Ritter arrived in the emergency room, but it was never done. The Ritter family attorney said if the x-ray exam had taken place, the actor would have undergone the proper treatment for a torn aorta.
But the attorney for codefendant cardiologist Dr. Joseph Lee argued that the actor arrived at the hospital in grave condition and that Lee was constrained for time to keep Ritter alive.
The trial began in February and lasted a little over a month. The jury started deliberating on Thursday and reached its nine to three verdict in favor of the doctors one and a half days later. Eight other medical personnel and the hospital settled earlier lawsuits with Ritter's widow and children, who received $14 million each.
Ritter won an Emmy for his portrayal of Jack Tripper in the popular 1970s sitcom "Three's Company."
For more information from the Diagnostic Imaging archives:
Malpractice awards vary widely for thoracic/GI imaging
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.